WALTHAM, Massachusetts, 07 mars 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, un laboratoire biopharmaceutique d’envergure mondiale déterminé à rejoindre les leaders du développement et de la [...] Read more »
Zenas BioPharma Nomeia Patricia Allen para o Conselho Diretor
WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacêutica global comprometida em se tornar líder no desenvolvimento e comercialização de terapias voltadas [...] Read more »
Zenas BioPharma beruft Patricia Allen in den Verwaltungsrat
WALTHAM, Massachusetts, March 07, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, ein weltweit tätiges Biopharmazieunternehmen, dessen Ziel eine führende Rolle in der Entwicklung und Kommerzialisierung von [...] Read more »
Zenas BioPharma Appoints Patricia Allen to its Board of Directors
WALTHAM, Mass., March 06, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology–directed [...] Read more »
Curia ernennt Steve Lavezoli zum Vice President, Biologika
ALBANY, New York, Feb. 23, 2024 (GLOBE NEWSWIRE) — Curia, ein führendes Auftragsforschungs–, Entwicklungs– und Produktionsunternehmen, hat heute bekanntgegeben, dass Steve Lavezoli mit Wirkung vom 26. [...] Read more »
Curia Nomeia Steve como Vice-Presidente, Divisão Biológica
ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) — A Curia, uma organização líder em pesquisa, desenvolvimento e fabricação por contrato, anunciou hoje a nomeação de Steve [...] Read more »
Curia nomme Steve Lavezoli vice-président de sa division Produits biologiques
ALBANY, New York, 23 févr. 2024 (GLOBE NEWSWIRE) — Curia, l’un des principaux organismes de recherche, de développement et de fabrication sous contrat, a annoncé aujourd’hui la nomination de [...] Read more »
Curia Appoints Steve Lavezoli as Vice President, Biologics
ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics [...] Read more »
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
JUPITER, Fla. and NES–ZIONA, Israel, Feb. 23, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced microbial [...] Read more »
Un meilleur accès aux soins et une expertise en matière de chaîne du froid renforcée pour Fortrea avec le développement de FortreaRx™
DURHAM, État de Caroline du Nord, 21 févr. 2024 (GLOBE NEWSWIRE) — Read more »